HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glycosyltransferases involved in type 1 chain and Lewis antigen biosynthesis exhibit glycan and core chain specificity.

Abstract
Sialyl Lewis A (SLe(a)), Lewis A (Le(a)), and Lewis B (Le(b)) have been studied in many different biological contexts, for example in microbial adhesion and cancer. Their biosynthesis is complex and involves beta1,3-galactosyltransferases (beta3Gal-Ts) and a combined action of alpha2- and/or alpha4-fucosyltransferases (Fuc-Ts). Further, O-glycans with different core structures have been identified, and the ability of beta3Gal-Ts and Fuc-Ts to use these as substrates has not been resolved. Therefore, to examine the in vivo specificity of enzymes involved in SLe(a), Le(a), and Le(b) synthesis, we have transiently transfected CHO-K1 cells with relevant human glycosyltransferases and, on secreted reporter proteins, detected the resulting Lewis antigens on N- and O-linked glycans using western blotting and Le-specific antibodies. beta3Gal-T1, -T2, and -T5 could synthesize type 1 chains on N-linked glycans, but only beta3Gal-T5 worked on O-linked glycans. The latter enzyme could use both core 2 and core 3 precursor structures. Furthermore, the specificity of FUT5 and FUT3 in Le(a) and Le(b) synthesis was different, with FUT5 fucosylating H type 1 only on core 2, but FUT3 fucosylating H type 1 much more efficient on core 3 than on core 2. Finally, FUT1 and FUT2 were both found to direct alpha2-fucosylation on type 1 chains on both N- and O-linked structures. This knowledge enables us to engineer recombinant glycoproteins with glycan- and core chain-specific Lewis antigen substitution. Such tools will be important for investigations on the fine carbohydrate specificity of Le(b)-binding lectins, such as Helicobacter pylori adhesins and DC-SIGN, and may also prove useful as therapeutics.
AuthorsJan Holgersson, Jonas Löfling
JournalGlycobiology (Glycobiology) Vol. 16 Issue 7 Pg. 584-93 (Jul 2006) ISSN: 0959-6658 [Print] England
PMID16484342 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 3-aminopropyl fucopyranosyl-1-2-galactopyranosyl-1-3-(fucopyranosyl-1-4)-2-acetamido-2-deoxyglucopyranosyl-1-3-galactopyranosyl-1-4-glucopyranoside
  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • DU-PAN-2 antigen, human
  • Glycoproteins
  • Lewis Blood Group Antigens
  • Lewis a oligosaccharide
  • Oligosaccharides
  • Polysaccharides
  • Serum Albumin
  • Glycosyltransferases
  • B3GALT5 protein, human
  • Fucosyltransferases
  • Galactosyltransferases
  • galactoside 2-alpha-L-fucosyltransferase
Topics
  • Animals
  • Antibodies, Monoclonal (immunology)
  • Antigens, Neoplasm (analysis, biosynthesis, immunology)
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Fucosyltransferases (genetics, metabolism)
  • Galactosyltransferases (genetics, metabolism)
  • Glycoproteins (chemistry)
  • Glycosyltransferases (genetics, metabolism)
  • Humans
  • Lewis Blood Group Antigens
  • Mice
  • Oligosaccharides (analysis, biosynthesis, immunology)
  • Polysaccharides (metabolism)
  • Serum Albumin (chemistry)
  • Substrate Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: